Author(s):
Diptimayee Jena, Satyabadi Sahoo, Pritam Mohanty, Debashis Mishra, Kirtimaya Mishra
Email(s):
drkirtimayamishra@gmail.com
DOI:
10.52711/2231-5659.2025.00061 
Address:
Diptimayee Jena, Satyabadi Sahoo, Pritam Mohanty, Debashis Mishra, Kirtimaya Mishra*
School of Pharmacy and Life Sciences, Centurion University of Technology and Management, Odisha.
*Corresponding Author
Published In:
Volume - 15,
Issue - 4,
Year - 2025
ABSTRACT:
Acyclovir (AVR), an antiviral drug often used to treat herpes simplex and varicella-zoster infections, necessitates precise and repeatable measurement for quality control, pharmacokinetic investigations, and therapeutic monitoring. This review examines both developing and known analytical approaches for determining AVR. Chromatography, spectrophotometry, electrochemical methods, and newer approaches, such as hyphenated and sensor-based methods, are critically evaluated as to sensitivity, accuracy, economical, and applicability across a wide range of dimensions. Analytical researchers often employ quality by design or design by expert techniques for improve method validation. Which make quick review that can help analysts select and validate the optimum analytical procedure. Recent innovations, such as nanotechnology-based sensors and green analytical techniques, are highlighted for their potential to improve detection capacities while also addressing environmental problems. The paper also looks at the limitations of established approaches and potential future paths for innovative analytical tools. This effort intends to help researchers and practitioners choose acceptable methodologies for AVR quantification, supporting improvements in antiviral medication analysis.
Cite this article:
Diptimayee Jena, Satyabadi Sahoo, Pritam Mohanty, Debashis Mishra, Kirtimaya Mishra. Emerging and Established Methods for Acyclovir Quantification: A Detailed Review. Asian Journal of Research in Pharmaceutical Sciences. 2025; 15(4):409-7. doi: 10.52711/2231-5659.2025.00061
Cite(Electronic):
Diptimayee Jena, Satyabadi Sahoo, Pritam Mohanty, Debashis Mishra, Kirtimaya Mishra. Emerging and Established Methods for Acyclovir Quantification: A Detailed Review. Asian Journal of Research in Pharmaceutical Sciences. 2025; 15(4):409-7. doi: 10.52711/2231-5659.2025.00061 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2025-15-4-11
REFERENCE:
1. Kausar S. Khan FS. Rehman MIM. Akram M. Riaz M. Rasool G. Khan AH. Saleem I. Shamim S. Malik A. A review: Mechanism of action of antiviral drugs. International Journal of Immunopathology and Pharmacology. 2021; 35: 1–12. doi: 10.1177/20587384211002621.
2. Mishra K. Padmasri B. Vegesna S. Jabeen A. Dash A. Kumar S. Jena D. Chemometric Assisted UV-Spectrophotometric Quantification of Cefaclor in Suspension Dosage Form. International Journal of Pharmaceutical Quality Assurance. 2023; 14(3): 734-739.
3. Seley-Radtke KL. Yates MK. The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold, Antiviral Research. 2018; 154: 66–86.doi: 10.1016/j.antiviral.2018.04.004.
4. Whitley RJ. Gnann JW Jr. Acyclovir: A decade later, New England Journal of Medicine. 1992; 327(11): 782-9. doi: 10.1056/NEJM199209103271108.
5. Sharma S. goyal S. Chauhan K. A review on analytical method development and validation. International Journal of Applied Pharmaceutics. 2018; 10(6): 8-15. doi: http://dx.doi.org/10.22159/ijap.2018v10i6.28279.
6. Rina R. Baile M. Jain A. A Review: Analytical Method Development and Validation, Systematic Reviews in Pharmacy. 2021; 12(8):450-454
7. Mishra K. Sahoo S. Mahato P. Singh NK. Jena D. Advancing Azelnidipine Dosage Form Analysis: A Quality by Design Guided Journey with Green Chemistry Innovations. African Journal of Biological Sciences. 2024; 6(11): 423-434.
8. Gowthami PRS. Rao GD. A review on analytical method development. Indian Journal of Research in Pharmacy and Biotechnology. 2014; 2(3): 1183-1195
9. Mishra K. Jena D. Nayak NB. Jabeen A. Dash A. Sahoo S. Jena D. Advanced, Simple, Sensitive, Selective Reverse Phase Liquid Chromatography Technique for The Quantitative Determination of Ritonavir and Lopinavir in In-House Dosage Form. Bulletin of Environment, Pharmacology and Life Sciences. 2023; 12(11): 217-222.
10. Sharma S. Singh N. Ankalgi AD. Rana A. Ashawat MS. Modern Trends in Analytical Techniques for Method Development and Validation of Pharmaceuticals: A Review. Journal of Drug Delivery and Therapeutics. 2021; 11(1-s): 121-130 doi: http://dx.doi.org/10.22270/jddt.v11i1-s.4515
11. Verch T. Campa C. Cyrille C. Frenkel CR. Graul T. Jaya N. Nakhle B. et al. Analytical Quality by Design, Life Cycle Management, and Method Control. The American Association of Pharmaceutical Scientists. 2022; 24(1): 34. doi: 10.1208/s12248-022-00685-2.
12. Lal B. Kapoor DU. Jaimini M. A review on analytical method validation and its regulatory perspectives. Journal of Drug Delivery and Therapeutics.2019; 9(2): 501-506. doi:10.22270/jddt. v9i2.2403.
13. Siddiqui MR. Zeid A. Rahman AN. Analytical techniques in pharmaceutical analysis: A review. Arabian Journal of Chemistry. 2017; 10: S1409–S1421
14. Kim EJ. Kim JH. Kim MS. Jeong SH. Choi DH. Process Analytical Technology Tools for Monitoring Pharmaceutical Unit Operations: A Control Strategy for Continuous Process Verification. Pharmaceutics. 2021; 13(6): 919. doi: 10.3390/pharmaceutics13060919
15. Badgujar VM. Jain PS. Advances in Analytical Techniques, Method Development, And Validation Protocols in Pharmaceutical Research, International Journal of Pharmaceutical Sciences. 2024; 2(3): 728-738. doi: https://doi.org/10.5281/zenodo.10845542
16. Mishra P. Pandey CM. Singh U. Keshri A. Sabaretnam M. Selection of appropriate statistical methods for data analysis. Annals of Cardiac Anaesthesi. 2019; 22: 297-301.
17. Munteanu IG. Apetrei C. Analytical Methods Used in Determining Antioxidant Activity: A Review. International Journal of Molecular Sciences. 2021; 22(7): 3380. doi: 10.3390/ijms22073380.
18. Shabir GA. Validation of high-performance liquid chromatography methods for pharmaceutical analysis: Understanding the differences and similarities between validation requirements of the US Food and Drug Administration, the US Pharmacopeia and the International Conference on Harmonization. Journal of Chromatography A. 2003; 987(1–2): 57-66
19. Reolon J. Brustolin M. Haas SE. Bender EA. Malesuik MD. Colome LM. Development and validation of high-performance liquid chromatography method for the simultaneous determination of acyclovir and curcumin in polymeric microparticles. Journal of Applied Pharmaceutical Science. 2018; 8(1): 136-141.
20. Naik RM. Ahmed S. Reddy GNK. RP-HPLC Method Development and Validation for Simultaneous Estimation of Hydrocortisone and Acyclovir in Pharmaceutical Dosage Forms. American Journal of Pharmacy and Health Research. 2018; 6(6): 5-18.
21. Mulabagal V. Annaji M. Kurapati S. Dash RP. Srinivas NR. Tiwari AK. Babu RJ. Stability-indicating HPLC method for acyclovir and lidocaine in topical formulations. Biomedical Chromatography. 2020; 34(3): e4751.doi: 10.1002/bmc.4751. Epub 2020 Jan 12.
22. Kumar YP. Sreedhar C. Rao ST. Akkamma HG. Reddy GB. Shrestha DM. New Analytical Method Development and Validation of Acyclovir by Rp-Hplc Method. Unique Journal of Pharmaceutical and Biological Sciences. 2016; 4(2):20-26.
23. Stulzer HK. Tagliari MP. Murakami FS. Silva MAS. Laranjeira MCM. Development and Validation of an RP-HPLC Method to Quantitate Acyclovir in Cross-Linked Chitosan Microspheres Produced by Spray Drying. Journal of Chromatographic Science. 2008; 46: 496-500.
24. Ghumre SV. Jadhav VM. Kadam VJ. High Pressure Liquid Chromatographic Method Development andValidationfor Estimation of Acyclovir in Bulk and Marketed Formulation. International Journal of Pharmaceutical Sciences and Research. 2016; 7(5): 2194-2200.
25. Hamdi A. Fegast R. Berka B. Clarck BJ. Stability test of Acyclovir at severe conditions. Asian Journal of Chemistry. 2005 17(4): 2699-2704.
26. Quadeib BTA. A simple RP-HPLC method for Acyclovir determination in tablet and cream dosage forms. Drug Discovery. 2019; 13:107-114.
27. Ghosh S. Sahu A. Kumar DS. Jena S. Harani A. Reddy TPK. Tanuja D. Method development and validation for acyclovir in tablet dosage form by RP-HPLC. Journal of Pharmacy Research. 2012; 5(3): 1785-1786.
28. Mule SG. Patre NG. Kshirsagar AD. Kharwade SB. The Estimation of Acyclovir in Bulk and Tablet Dosage form by Using Specificity and Analytical Method Development. Acta Scientific Pharmaceutical Sciences. 2022; 6(3): 9-12.
29. Manoharan G. Mohamed RAW. Development and Validation of a Stability-Indicating RP-HPLC Method for the Estimation of Aciclovir in Bulk and Ointment Dosage Form. International Journal of Pharmaceutical and Phytopharmacological Research. 2019; 9(1): 11-18.
30. Kumar CV. Kumar DA. Rao JVLNS. Development and Validation of Rp-Hplc Method for the Determination of Acyclovir in Human Plasma. International Journal of Chemical Science. 2010; 8(1): 475-482.
31. Muralidharan S. Kalaimani J. Parasuraman S. Dhanaraj SA. Development and Validation of Acyclovir HPLC External Standard Method in Human Plasma: Application to Pharmacokinetic Studies. Advances in Pharmaceutics. 2014; 1-5.
32. Ravisankar P. Niharika A. Sireesha S. Koushik OS. Himaja V. Development and Validation of Rp-Hplc Method for Quantitative Estimation of Acyclovir in Bulk Drug and Tablets. Journal of Chemical and Pharmaceutical Sciences. 2015; 8(1): 73-80
33. Dessai P. FatrekarN. Stability Indicating Method Developmnt and Validation of Uv Method for the Determination of Acyclovir in Tablet Dosage Form. Indo American Journal of Pharmaceutical Sciences. 2018; 5(9): 8955-8960.
34. Lasure A. Ansari A. Kalshetti M. UV Spectrophotometric Analysis and Validation of Acyclovir in Solid Dosage Form, International Journal of Current Pharmaceutical Research. 2020; 12(2): 100-103
35. Paul D. Sanap G. Shenoy S. Kalyane D. Kalia K. Tekade RK. Artificial intelligence in drug discovery and development. Drug Discovery Today. 2021; 26(1): 80-93. doi: 10.1016/j.drudis.2020.10.010
36. Jang IJ. Artificial intelligence in drug development: clinical pharmacologist perspective. Translational and Clinical Pharmacology. 2019; 27(3): 87-88. doi: 10.12793/tcp.2019.27.3.87.
37. Hughes JP. Rees S. Kalindjian SB. Philpott KL. Principles of early drug discovery. British Journal of Pharmacology. 2011; 162(6): 1239-49. doi: 10.1111/j.1476-5381.2010. 01127.x
38. Pramod K. Tahir MA. Charoo NA. Ansari SH. Ali J. Pharmaceutical product development: A quality by design approach. International Journal of Pharmaceutical Investigation. 2016; 6(3): 129-38. doi: 10.4103/2230-973X.187350
39. Popkin ME. Goese M. Wilkinson D. Finnie S. Flanagan T. Campa C. Clinch A. Teasdale A. Lennard A. Cook G. Mohan G. Osborne MD. Chemistry Manufacturing and Controls Development. Industry Reflections on Manufacture, and Supply of Pandemic Therapies and Vaccines. American Association of Pharmaceutical Scientists. 2022; 24(6): 101. doi: 10.1208/s12248-022-00751-9
40. Algorri M. Cauchon NS. Abernathy MJ. Transitioning Chemistry, Manufacturing, and Controls Content with a Structured Data Management Solution: Streamlining Regulatory Submissions. Journal of Pharmaceutical Sciences. 2020; 109(4):1427-1438
41. Chiodin D. Cox EM. Edmund AV. Kratz E. Lockwood SH. Regulatory Affairs 101: Introduction to Investigational New Drug Applications and Clinical Trial Applications. Clinical and Translational Science. 2019; 12(4): 334-342. doi: 10.1111/cts.12635.
42. Samara C. Garcia A. Henry C. Vallotton L. Cariolato L. Desmeules J. Pincon A. Safety Surveillance During Drug Development: Comparative Evaluation of Existing Regulations. Advances in Therapy. 2023; 40(5):2147-2185. doi: 10.1007/s12325-023-02492-3.
43. Yao B. Zhu L. Jiang Q. Xia HA. Safety monitoring in clinical trials. Pharmaceutics. 2013; 5(1): 94-106. doi: 10.3390/pharmaceutics5010094
44. Krishnan B. Mishra K. Quality by Design based Development and Validation of RP-HPLC Method for Simultaneous Estimation of Sitagliptin and Metformin in Bulk and Pharmaceutical Dosage Forms. International Journal of Pharmaceutical Investigation. 2020; 10(4): 512-518.
45. Buckley LA. Bebenek I. Cornwell PD. Hodowanec A. Jensen EC. Murphy C. Ghantous HN. Drug Development 101: A Primer. International Journal of Toxicology. 2020; 39(5): 365-495
46. Balamurugan K. Mishra K. Optimization and Validation of the Simultaneous Determination of Vildagliptin and Metformin, in Bulk and Formulation by A Reverse Phase HPLC Method Using D-Optimal Experimental Design. Journal of Global Pharma Technology. 2020; 12(8):1-12.
47. Azadeh M. Sondag P. Wang Y. Raines M. Sailstad J. Quality Controls in Ligand Binding Assays: Recommendations and Best Practices for Preparation, Qualification, Maintenance of Lot-to-Lot Consistency, and Prevention of Assay Drift. American Association of Pharmaceutical Scientists. 2019; 21(5): 89. doi: 10.1208/s12248-019-0354-6
48. Song JG. Baral KC. Kim GL. Park JW. Seo SH. Kim DH. Jung DH. Ifekpolugo NL. Han HK. Quantitative analysis of therapeutic proteins in biological fluids: recent advancement in analytical techniques. Drug Delivery. 2023; 30(1): 2183816. doi: 10.1080/10717544.2023.2183816
49. Reddy MR. Mishra K. Suresh R. Development and Validation of a Liquid Chromatographic Method for the Determination of Selected Anti Cancer Drugs in Bulk and Pharmaceutical Formulations. International Journal of Pharma Research and Health Sciences. 2018; 6(1): 2303-07.
50. Cortese M. Gigliobianco MR. Magnoni F. Censi R. di Martino PD. Compensate for or Minimize Matrix Effects? Strategies for Overcoming Matrix Effects in Liquid Chromatography-Mass Spectrometry Technique: A Tutorial Review. Molecules. 2020; 25(13): 3047. doi: 10.3390/molecules25133047
51. Clark KD. Zhang C. Anderson JL. Sample Preparation for Bioanalytical and Pharmaceutical Analysis. Analytical chemistry. 2016; 88(23): 11262-11270.
52. Dwivedi YK. Sharma A. Rana NP. Giannakis M. Goel P. Dutot V. Evolution of artificial intelligence research in Technological Forecasting and Social Change: Research topics, trends, and future directions. Technological Forecasting and Social Change. 2023; 192: 122579.
53. Park G. Kim MK. Go SH. Choi M. Jang YP. Analytical Quality by Design (AQbD) Approach to the Development of Analytical Procedures for Medicinal Plants. Plants (Basel). 2022; 11(21): 2960. doi: 10.3390/plants11212960
54. Sangshetti JN. Deshpande M. Zaheer Z. Shinde DB. Arote R. Quality by design approach: Regulatory need. Arabian Journal of Chemistry. 2017; 10(supplement 2): S3412-S3425
55. Gutierrez L. Cauchon NS. Christian TR. Giffin MJ. Abernathy MJ. The Confluence of Innovation in Therapeutics and Regulation: Recent CMC Considerations. Journal of Pharmaceutical Sciences. 2020; 109(12): 3524-3534. doi: 10.1016/j.xphs.2020.09.025
56. Nupur N. Joshi S. Gulliarme D. Rathore AS. Analytical Similarity Assessment of Biosimilars: Global Regulatory Landscape, Recent Studies and Major Advancements in Orthogonal Platforms. Frontiers in Bioengineering and Biotechnology. 2022; 10: 832059. doi: 10.3389/fbioe.2022.832059
57. Vora LK. Gholap AD. Jetha K. Thakur RRS. Solanki HK. Chavda VP. Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design. Pharmaceutics. 2023; 15(7):1916. doi: 10.3390/pharmaceutics15071916
58. Kapustina O. Burmakina P. Gubina N. Serov N. Vinogradov V. User-friendly and industry-integrated AI for medicinal chemists and pharmaceuticals. Artificial Intelligence Chemistry. 2024; 2(2): 100072
59. Sampene AK. Nyirenda F. Evaluating the effect of artificial intelligence on pharmaceutical product and drug discovery in China. Future Journal of Pharmaceutical Sciences. 2024; 10: 58. https://doi.org/10.1186/s43094-024-00632-2
60. Yin L. Yu L. Guo Y. Wang C. Ge Y. Zheng X. Zhang N. You J. Zhang Y. Shi M. Green analytical chemistry metrics for evaluating the greenness of analytical procedures. Journal of Pharmaceutical Analysis. 2024; 14(11): 101013